Dysphonia induced by vascular endothelium growth factor/vascular endothelium growth factor receptor inhibitors.
Hartl
Dana M
DM
Department of Otolaryngology Head & Neck Surgery, Institut Gustave Roussy, Paris, France. dana.hartl@igr.fr
Ferté
Charles
C
Loriot
Yohann
Y
Gomez Roca
Carlos
C
Bahleda
Rastislav
R
Moldovan
Cristian
C
Mir
Olivier
O
Soria
Jean-Charles
JC
D000162:Acoustics; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000494:pharmacology*; D055154:Dysphonia / Q000139:chemically induced* / Q000503:physiopathology; D005260:Female; D006801:Humans; D007830:Larynx / Q000002:abnormalities / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D040262:Receptors, Vascular Endothelial Growth Factor / Q000037:antagonists & inhibitors* / Q000378:metabolism; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors* / Q000378:metabolism
D000970:Antineoplastic Agents; D042461:Vascular Endothelial Growth Factor A; D040262:Receptors, Vascular Endothelial Growth Factor